wiis/wiːs/Write It, I'll Share

Fair-Value Report — China Merchants China Direct Investments (0133.HK)

by hkse-stock-research

HK:0133 · Investment Holding / Closed-End Fund · Hong Kong Stock Exchange
招商中國直接投資有限公司
Speculative Buy Fair Value HK$23.4 Price HK$19.44 (Jun 26, 2026) +20% Upside + 4% Yield 51.6% Discount to Verified NAV Insider: TFI/Tianfeng +2.04% → 11.81%

Insider Signal

FieldDetail
Filer (holder)TFI Asset Management (Cayman) Ltd. — 天風國際資產管理有限公司, HK subsidiary of Tianfeng Securities Co., Ltd. (601162.SS), a PRC securities firm listed on Shanghai Stock Exchange. Holds Type 9 (asset management) SFC licence. This is a licensed external fund manager, NOT a broker, custodian, nominee, or related party of China Merchants Group.
Reason code1101 / 1103 — On-exchange and/or off-exchange open-market purchase of existing shares at prevailing market price
Transaction dateJune 26, 2026 — one day after CMCDI announced expiry of CMCIM's Investment Management Agreement and appointment of new CIO / Administrative GM / CFO (June 25 announcement)
Shares acquired (est.)~3.11 million shares at ~HK$19.44 per share
Total considerationHK$60,497,280 (~HK$60.5M)
Holding before~9.77% of issued share capital
Holding after11.81% — a very substantial existing position further enlarged
Signal qualityGenuine open-market accumulation. NOT a subscription of new shares, placing, rights issue, pledged-share artifact, intra-group reshuffle, or employee scheme. TFI/Tianfeng is entirely independent of China Merchants Group and First Eastern Investment Group. The timing — buying one day after a management-internalization announcement that triggered a share-price pullback — signals conviction on the governance transformation.
CaveatThe HKEX DI form designates TFI as a clients account, meaning TFI acts as fund manager deploying client capital, not proprietary capital. This slightly reduces the "skin-in-the-game" purity of the signal, but TFI's 11.81% stake still represents a very large concentrated bet by a professional institutional manager.

Verified Market Snapshot

Price
HK$19.44
Jun 26, 2026 (prev. close)
Market Cap
~HK$2.96B
~US$379M at 7.80 HKD/USD
Shares Out.
~152.4M
Derived: US$834.65M NAV ÷ US$5.479/share (Dec 31, 2025)
NAV/Share (May 31)
HK$40.18
Verified: company website June 2026; US$5.128
Discount to NAV
51.6%
vs May 31, 2026 verified NAV
Dividend (TTM)
HK$0.78
Yield: 4.01% at HK$19.44
FY2025 Net Profit
US$190M
+57.8% YoY; driven by Arashi Vision fair-value uplift
52-Week Range
HK$13.20–28.78
Current near mid-range; down ~32% from recent high
NAV Recency Note: The most recently published NAV per share is HK$40.18 as at May 31, 2026 (approximately 4 weeks before the valuation date). The June 2026 monthly update has not yet been published. Since May 31, China Merchants Bank (3968.HK, CMCDI's largest holding at ~40% of Dec 31 NAV) has declined from an estimated HK$50 to HK$45.26 (Jun 23), and Arashi Vision (688775.SS, ~22% of Dec 31 NAV) has fallen to CNY 131.85 — near its 52-week low of CNY 131.50. The estimated June 26, 2026 NAV is approximately HK$37–38 per share (a 5–7% decline from the May 31 verified figure). At HK$19.44 vs estimated HK$37.5 NAV, the discount to estimated current NAV is approximately 48%. All valuation scenarios below use the estimated June 2026 NAV; the May 31 figure is used as the verified reference.

Business Overview

China Merchants China Direct Investments Ltd. (CMCDI, 0133.HK) is a Hong Kong-listed, closed-end investment fund structure backed by China Merchants Group, one of China's largest state-owned enterprise conglomerates (founded 1872). CMCDI was established to make long-term direct investments in PRC-based companies across financial services, information technology (AI, fintech, healthcare), cultural industries, and emerging sectors.

Until June 30, 2026, CMCDI was externally managed by China Merchants China Investment Management Limited (CMCIM), a joint venture between China Merchants Group and First Eastern Investment Group (led by Victor Chu). On June 25, 2026 — one day before the DI filing that triggered this analysis — CMCDI announced the expiry of the CMCIM Investment Management Agreement and the concurrent appointment of a new internal team (Chief Investment Officer, Administrative General Manager, Chief Financial Officer). This marks a transition from external to self-managed governance, effective July 1, 2026.

This transition is the central catalyst: shareholders had previously rejected a proposed 3-year extension of the CMCIM mandate (indicating dissatisfaction), and the company subsequently extended CMCIM for only 6 months (Jan–Jun 2026) while transitioning to internal management. The management fee under the final 6-month agreement was capped at HK$8M total (about 0.12% of NAV annually), so the financial benefit of internalization is modest. The real driver of any discount-narrowing thesis is governance improvement, shareholder alignment, and market confidence, not fee savings.

Portfolio (Dec 31, 2025 — Most Recent Audited)

HoldingTypeSector Value (Dec 31, 2025) % of Dec 31 NAV Current Status / Notes
China Merchants Bank (3968.HK)Listed (HKEX / A-share)BankingUS$331M39.7%H-share at HK$45.26 (Jun 23, 2026); down from ~52-week high of HK$56.30. Largest holding and key NAV swing factor.
China Credit Trust Co., Ltd.UnlistedTrust / FinanceUS$188M22.5%Privately held trust company; illiquid. One of China's largest trust companies. Valuation is book-based, not mark-to-market.
Arashi Vision Inc. (688775.SS)Listed (SSE STAR)Consumer Tech (cameras)US$187M22.4%Insta360 maker. Stock at CNY 131.85 (Jun 26, 2026) — near 52-week low CNY 131.50 — vs ATH CNY 377.77 (Sep 2025). Estimated current stake value: ~US$95M (approx. 50% decline from year-end). HIGH RISK to near-term NAV.
iFLYTEK Co., Ltd. (002230.SZ)Listed (A-share)AI / Speech TechUS$49M5.9%China's leading AI speech platform. Listed Shenzhen A-share.
Xunfei Healthcare TechnologyListed (SSE STAR)Healthcare / AIUS$43M5.2%AI-powered healthcare subsidiary of iFLYTEK.
NBA China, L.P.Unlisted (PE)Sports / MediaUS$39M4.7%Minority stake in NBA China operations. Illiquid, long-horizon.
Pony AI (formerly)Sold post year-endAutonomous Driving——Disposed in early 2026 for US$18.31M proceeds; removed from portfolio.
JIC Leasing (pending)Pending saleLeasing / Finance——Agreed disposal ~US$38.68M pending; will convert to cash on completion.
Other holdings / cashVariousMixed~US$90M~10.8%Residual positions + cash; JIC Leasing proceeds and Pony AI proceeds to be added to cash.

Source: CMCDI 2025 Annual Report (December 31, 2025). Current prices: CMB 3968.HK at HK$45.26 (Jun 29, 2026, StockAnalysis); Arashi Vision 688775.SS at CNY 131.85 (Jun 26, 2026, StockAnalysis). Post-year-end events confirmed via minichart.com.sg/2026/04/23 CMCDI AR summary.

Valuation: SOTP / Discount-to-NAV Methodology

Method rationale: CMCDI is a closed-end investment fund holding a mix of listed and unlisted PRC assets. The correct primary method is discount-to-NAV (SOTP), not a traditional revenue-based DCF. The NAV is the intrinsic anchor; the discount at which shares trade reflects market confidence in management, portfolio quality, liquidity, and governance. Management internalization is the key variable for discount narrowing. A supplementary P/E check is provided but is low-information given CMCDI's earnings come primarily from fair-value movements rather than recurring cash earnings.

WACC Reference (CAPM)

InputValueSource
Risk-free rate (HK 10Y proxy, USD peg)3.80%US 10Y approximate; HKD pegged to USD
Beta (vs HKEX)0.47StockAnalysis.com (5Y)
Equity Risk Premium (HK)5.50%Damodaran implied ERP for HK
Country Risk Premium1.00%HK-listed, PRC assets; modest uplift
Cost of Equity7.38%CAPM output
Debt weight (nominal, nearly all-equity)2%Investment holding structure
WACC7.32%scripts/wacc.py output

Scenario Analysis — NAV and Discount-to-NAV

Each scenario projects (a) the 12-month forward NAV per share and (b) the discount at which shares are expected to trade, reflecting the probability of successful management internalization and portfolio performance.

Scenario Weight Key Assumptions 12m NAV / Share (HKD) Target Discount Target Price (HKD) Return vs HK$19.44
Bull 25% Internalization succeeds; new team delivers clarity. CMB recovers to HK$52, Arashi Vision stabilizes at CNY 150. JIC Leasing/Pony proceeds deployed well. Discount narrows sharply as governance discount is removed. HK$42 28% HK$30.2 +55%
Base 50% Partial improvement; new team credible but slow to prove. CMB stays around HK$48–50. Arashi Vision stabilizes ~CNY 135–140. Discount narrows moderately as market recognizes undervaluation. HK$38 38% HK$23.6 +21%
Bear 25% Management transition rocky; key talent departs CMCIM, new internal team lacks portfolio knowledge. CMB falls to HK$40 on China macro stress. Arashi Vision drops to CNY 100. Discount stays wide (50%) as confidence erodes. HK$32 50% HK$16.0 −18%
Probability-Weighted Fair Value 0.25 × HK$30.2 + 0.50 × HK$23.6 + 0.25 × HK$16.0 — — HK$23.4 +20.4%

Plus dividend yield of ~4.0% (HK$0.78 TTM, assuming maintained). Total return potential: approximately 24% over 12–18 months. Income while waiting for discount to narrow.

Reverse Read — What the Current Price Implies

At HK$19.44, the market prices in a permanent 48–52% discount to NAV. This is more severe than Fosun International (0656.HK, 78% discount but actively distressed with leverage and losses) on a quality-adjusted basis, and far wider than typical HK SOE investment holding discounts of 25–40%. To justify HK$19.44 in the base case, one would need to believe either (a) NAV deteriorates another 30% AND the discount stays at 40%, or (b) management internalization completely fails AND the portfolio marks down. Neither scenario is remotely the base case for a China Merchants Group-backed entity with US$834M in audited net assets and zero reported financial distress. The market appears to be pricing in excessive governance uncertainty — precisely the event that TFI/Tianfeng is betting on resolving.

Peer Comparison

For HK-listed investment holding/closed-end vehicles. Primary metric: Price/NAV (P/Book where NAV unavailable). Note: truly comparable pure closed-end fund peers are limited in HK; table below is the closest available set. Treat as directional cross-check only.

NameTicker Price (HKD) Mkt Cap P/NAV or P/B NAV/Share Dividend Yield FY2025 Profit Notes
CMCDI (Target)0133.HK 19.44 ~HK$2.96B 0.48× HK$40.18 (May 31) 4.0% US$190M profit Internalization catalyst; zero financial distress; PRC PE + listed portfolio
China Everbright Ltd.0165.HK 5.40 HK$9.1B ~0.5–0.7× book (est.) N/A pub. 1.85% HK$(2.0B) loss SOE financial holding; loss-making in 2025; broader mandate than CMCDI
CITIC Limited0267.HK 11.70 HK$342.7B ~0.65× book (est.) N/A pub. 5.72% HK$65.4B profit Giant SOE conglomerate; operating businesses (not pure fund); P/E 5.3×
Fosun International0656.HK 3.97 HK$31.3B 0.22× NAV HK$18.1 N/M CNY (23.4B) loss Private PE holding; heavily leveraged; in financial restructuring — distressed comp
Median (excl. CMCDI) ~0.58× (est.)
CMCDI vs Median −17% to median (est.)

CMCDI trades at an estimated 17% below even the depressed median P/NAV/B of this peer group. The only true distressed comp (Fosun at 0.22×) explains why; CMCDI with zero leverage and profitable operations should logically trade at a premium to Fosun. The current discount is pricing in a risk level inappropriate for CMCDI's balance-sheet quality. Target is trading at approximately 17% discount to peer median P/NAV, which is NOT justified by fundamentals — CMCDI has superior balance-sheet quality and profitability vs the peer set.

Supplementary P/E Sanity Check

Low-information for investment holding cos (earnings are volatile mark-to-market). Presented for completeness only.

MetricValueNote
FY2025 EPS (derived)~US$1.247 (HK$9.72)US$189.94M ÷ 152.35M shares
Current P/E (trailing)2.0× TTMHK$19.44 ÷ HK$9.72
3-Year Average Net Profit~US$105M(FY25 US$190M + FY24 US$120M + FY23 US$6M) ÷ 3
Normalized P/E (3Y avg)~3.6×HK$2,961M ÷ (HK$105M × 7.80)
CITIC P/E (for context)5.3×Source: StockAnalysis

Even on normalized earnings, CMCDI trades below CITIC. This is directionally supportive but not the primary valuation method — earnings stability at CMCDI is low given fair-value accounting.

Conclusion

Rating: Speculative Buy | Fair Value: HK$23.4 | Price: HK$19.44 (Jun 26, 2026)

CMCDI presents a deep-discount-to-verified-NAV thesis with a specific near-term catalyst (management internalization) and evidence of institutional conviction (TFI/Tianfeng at 11.81% and growing). The 48–52% discount to NAV is extreme by any reasonable benchmark for a zero-leverage, China Merchants Group-backed investment vehicle with profitable operations.

The rating is Speculative rather than Moderate Buy because:

However, the risk-reward is asymmetric in the buyer's favour: the bear case at HK$16.0 (−18%) is capped by the portfolio's hard asset value, while the bull case at HK$30.2 (+55%) is entirely plausible if the management transition restores investor confidence. The 4.0% dividend yield is paid while waiting.

Signal real. Discount real. Catalyst real. But execution uncertain. Size accordingly.

Key Risks

Sources

Disclaimer: This report is produced for informational purposes only and does not constitute investment advice, a recommendation to buy or sell, or an offer or solicitation of an offer to buy or sell any security. The author holds no position in 0133.HK or any of its portfolio holdings and receives no compensation from any entity referenced in this report. Investing in Hong Kong-listed equities involves risks, including the risk of loss of all capital. Past performance is not indicative of future results. Fair-value estimates are forward-looking and inherently uncertain. NAV figures for CMCDI's unlisted holdings are management estimates and may not reflect actual realisable value. This report was prepared using publicly available information; accuracy of third-party sources cannot be guaranteed. Not investment advice. Please consult a licensed financial adviser before making investment decisions.

Discussion

No comments yet.

No redactions applied.

Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.